Predicting Response to Intra-Articular Corticosteroid Injection in Patients With Osteoarthritis of the Glenohumeral Joint
Status: | Recruiting |
---|---|
Conditions: | Osteoarthritis (OA) |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | 18 - 100 |
Updated: | 1/23/2019 |
Start Date: | April 18, 2018 |
End Date: | July 15, 2022 |
Contact: | Michelle Bruner, MSc |
Email: | bruneml@ortho.ufl.edu |
Phone: | 352-273-7337 |
This study will examine the effectiveness of a single cortisone injection in patients with
shoulder osteoarthritis over a 6-month period, and identify clinical and radiographic factors
to help predict how a patient with shoulder osteoarthritis will respond to a cortisone
injection utilizing ultrasound guidance.
shoulder osteoarthritis over a 6-month period, and identify clinical and radiographic factors
to help predict how a patient with shoulder osteoarthritis will respond to a cortisone
injection utilizing ultrasound guidance.
The purpose of this study is to assess the effectiveness of intraarticular corticosteroid
injections (IACSI) for glenohumeral arthritis by 1) through patient-reported outcomes and 2)
identifying clinical and radiographic predictors of IACSI success.
injections (IACSI) for glenohumeral arthritis by 1) through patient-reported outcomes and 2)
identifying clinical and radiographic predictors of IACSI success.
Inclusion Criteria:
- Patients with a diagnosis of symptomatic primary osteoarthritis of the shoulder will
be recruited from the patient population seeking treatment at the Orthopaedics Sports
Medicine Institute.
- those who have failed previous treatment including over-the-counter analgesics and
activity modification
- have elected to receive a medically-indicated, ultrasound-guided IACSI in the
shoulder.
Exclusion Criteria:
- Patients will be excluded from the study for any of the following reasons:
- Post traumatic osteoarthritis
- Inflammatory osteoarthritis
- Imaging confirmed rotator cuff tear
- Prior ipsilateral shoulder surgery
- Memory loss or inability to complete study measures
- History of allergy to injection medications
- Diabetic patients with patient-reported fasting blood glucose >200
- Prior injection in the ipsilateral shoulder within three months
We found this trial at
2
sites
3450 Hull Road
Gainesville, Florida 32611
Gainesville, Florida 32611
Principal Investigator: Bradley Schoch, M.D.
Phone: 352-273-7372
Click here to add this to my saved trials
3450 Hull Road
Gainesville, Florida 32611
Gainesville, Florida 32611
Principal Investigator: Bradley Schoch, M.D.
Phone: 352-273-7419
Click here to add this to my saved trials